Events
There is a lot of anticipated excitement for multiple sclerosis treatments unveiled by Biogen at the 34th Congress of the European Committee for Treatment and Research in MS in Berlin.
TESARO, Inc. today announced that data from six abstracts will be presented at the European Society for Medical Oncology (ESMO) Congress from October 19-23, 2018 in Munich, Germany.
Completion of multi-million Euro expansion of manufacturing capacity and deployment of next generation production technologies
New late-stage data released by Janssen shows that a single dose of Stelara can induce clinical reemission and response in adult patients with moderate to severe ulcerative colitis who have not had positive response from previous treatment options.
In looking at companies that are shaping the future, Time Magazine selected 50 business that are leading the charge. While many tech companies lead the way, there are several pharma and life science companies that are also disrupting the future.
Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation
From 1-4 October, more than 2,500 public health experts from over 120 countries convened in Kuala Lumpur at the 2018 World Cancer Congress (WCC).
Retrophin, Inc. today announced that it will present new data examining the long-term effects of sparsentan in focal segmental glomerulosclerosis (FSGS), at the American Society of Nephrology (ASN) Kidney Week 2018.
The ASSIST PLUS pipetting robot from INTEGRA Biosciences received a prestigious Basel Life MipTec Product Innovation Award 2018 at this year’s MipTec exhibition.
After negative reports about after-hours parties that have been deemed disrespectful toward women, and multiple reports about the lack of gender diversity on industry boards of directors, biotech’s biggest trade association is taking action.
PRESS RELEASES